Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » Abstracts

Abstracts

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 10/07/19 by Amreen Luhar

An audit of Abiraterone monitoring in prostate cancer patients

Abstracts

View resources
Last reviewed: 08/01/21 by Alice Tew

An audit of cardiac dysfunction monitoring an outcomes, in melanoma patients taking dabrafenib and trametinib.

Abstracts

View resources
Last reviewed: 10/07/19 by Rubena Begum

An Audit of Nurse-Led Screening of Denosumab on the Chemotherapy Day Unit at St Bart’s Hospital

Abstracts

View resources
Last reviewed: 10/07/19 by Alison Casey

An evaluation of the impact of a pharmacy staff training plan and counselling checklist on patient knowledge of oral systemic anti-cancer therapy (SACT)

Abstracts

View resources
Last reviewed: 10/07/19 by Olivia Watkins

An evaluation of the quantity and nature of interventions made by oncology pharmacists in outpatient clinics at Guy’s Cancer Centre

Abstracts

View resources
Last reviewed: 10/07/19 by Rebecca Clark

An evaluation of the time taken to implement a newly commissioned single agent ASCT medicine: NICE TA491. Ibrutinib for Waldenstrom’s macroglobulinaemia

Abstracts

View resources
Last reviewed: 10/07/19 by Vicki Portingale

Analysis of the pharmacy monitoring service for patients on oral anticancer treatments

Abstracts

View resources
Last reviewed: 10/07/19 by Apostolos Papachristos

Anti-Xa activity monitoring as a tool to optimise LMWH therapy in cancer patients

Abstracts

View resources
Last reviewed: 10/07/19 by Terry Chapman

Are all onocology products created equal? The impat of different polyolefin infusion bags on the physical stability of therapeutic proteins.

Abstracts

View resources
Last reviewed: 10/07/19 by Rinaldo Schipper

Assessment of drug supply reliability in Europe by evaluating on time in full (OTIF) delivery

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 42 43
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.